Latest News about TARO
Recent news which mentions TARO
The Daily Biotech Pulse: Sanofi-GlaxoSmithKline To Supply 200M Doses To COVID-19 Vaccine Alliance, Gilead Earnings, Biodesix Debuts
October 28, 2020
From Benzinga
Earnings Scheduled For October 28, 2020
October 28, 2020
From Benzinga
The Week Ahead In Biotech: Kala FDA Decision, Merck & Pfizer Earnings, Vaccine Updates And IPOs
October 25, 2020
From Benzinga
The Daily Biotech Pulse: Novavax Advances Vaccine, Marinus Gets Nod For Late-Stage Study, 3 IPOs
September 25, 2020
From Benzinga
The Daily Biotech Pulse: Legal Relief For Evolus, Fulgent to Join S&P SmallCap 600, AIM ImmunoTech's Positive Cancer Drug Readout
September 22, 2020
From Benzinga
From Benzinga
US Indicts Teva Pharmaceutical In Generic Drug Price-Fixing Case
August 25, 2020
From Benzinga
Drug maker Teva’s U.S. unit indicted on price-fixing charges
August 25, 2020
From MarketWatch
The Daily Biotech Pulse: Merck's Breakthrough Therapy Designation, Sonoma Surges On Sanitizer News, Sanofi-Glaxo And More
July 29, 2020
From Benzinga
Earnings Scheduled For July 29, 2020
July 29, 2020
From Benzinga
Why the FDA's Drug Competition Action Plan Is Bad News for Generic Pharmaceutical Stocks
June 03, 2020
From Motley Fool
From Benzinga
Earnings Scheduled For May 19, 2020
May 19, 2020
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
March 12, 2020
From Benzinga
Stocks That Hit 52-Week Lows On Friday
March 06, 2020
From Benzinga
The Daily Biotech Pulse: GenMark Diagnostics Ships COVID-19 Test Kits, Karyopharm To Offer Shares, And More
March 03, 2020
From Benzinga
Stocks That Hit 52-Week Lows On Friday
February 28, 2020
From Benzinga
The Daily Biotech Pulse: Sangamo In Genome-Editing Therapy Deal With Biogen, FDA Nod For Biohaven, Passage Bio IPO
February 28, 2020
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
February 27, 2020
From Benzinga
The Daily Biotech Pulse: Moderna Ships COVID-19 Vaccine For Clinics, Mallinckrodt Strikes $1.6B Opioid Settlement
February 25, 2020
From Benzinga
The Daily Biotech Pulse: FDA Approves Baudax Bio's Non-Opioid Pain Drug, Aerie Rallies On Q4 Results, D-Day For Esperion
February 21, 2020
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
February 20, 2020
From Benzinga
Stocks That Hit 52-Week Lows On Friday
February 14, 2020
From Benzinga
The Daily Biotech Pulse: Epizyme's Tazemetostat sNDA Accepted For Priority Review, Eisai To Withdraw Weight Loss Drug, Sol-Gel Prices Offering
February 14, 2020
From Benzinga
10 Biggest Price Target Changes For Tuesday
February 04, 2020
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.